EGFR and neoplasm: On the other hand, phenobarbital may not function as a prototypical EGFR inhibitor, such as gefitinib and erlotinib, which can antagonize EGFR-mediated cell proliferation and tumor development (Nakajima et al., 2012; Shin et al., 2013).